Literature DB >> 10914497

Vascular endothelial cells provide T cells with costimulatory signals via the OX40/gp34 system.

A Kunitomi1, T Hori, A Imura, T Uchiyama.   

Abstract

We investigated whether gp34, the ligand of OX40, expressed on EC is involved in costimulation of T cells. Normal CD4+ T cells were stimulated with anti-CD3-coated beads, phytohemagglutinin (PHA), or concanavalin A (Con A) in the presence or absence of irradiated human umbilical vein endothelial cells (HUVEC). Stimulation of T cells with each of these mitogens results in significant T-cell proliferation only when HUVEC were present, and this proliferation was inhibited markedly by anti-OX40 or anti-gp34 monoclonal antibody (mAb). T cells cultured with HUVEC produced more interleukin (IL)-2 than those cultured without HUVEC. The addition of anti-IL-2R alpha chain and anti-IL-2R beta chain mAbs abolished the costimulatory effects of HUVEC. Thus, the augmentation of T-cell proliferation appears to be attributable to increased IL-2 production. These results suggest that gp34 expressed on HUVEC plays a role in potentiation of T-cell immune response by providing OX40+ T cells with costimulatory signals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10914497

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  13 in total

1.  OX40 signaling renders adult T-cell leukemia cells resistant to Fas-induced apoptosis.

Authors:  Akane Kunitomi; Toshiyuki Hori; Michiyuki Maeda; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

2.  ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells.

Authors:  Saman Khayyamian; Andreas Hutloff; Kerstin Büchner; Michael Gräfe; Volker Henn; Richard A Kroczek; Hans W Mages
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

3.  Progenitor cell dose determines the pace and completeness of engraftment in a xenograft model for cord blood transplantation.

Authors:  Congxiao Liu; Benny J Chen; Divinomar Deoliveira; Gregory D Sempowski; Nelson J Chao; Robert W Storms
Journal:  Blood       Date:  2010-09-10       Impact factor: 22.113

4.  Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions.

Authors:  Candice Chapouly; Azeb Tadesse Argaw; Sam Horng; Kamilah Castro; Jingya Zhang; Linnea Asp; Hannah Loo; Benjamin M Laitman; John N Mariani; Rebecca Straus Farber; Elena Zaslavsky; German Nudelman; Cedric S Raine; Gareth R John
Journal:  Brain       Date:  2015-03-23       Impact factor: 13.501

Review 5.  Control of immunity by the TNFR-related molecule OX40 (CD134).

Authors:  Michael Croft
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

Review 6.  Roles of OX40 in the pathogenesis and the control of diseases.

Authors:  Toshiyuki Hori
Journal:  Int J Hematol       Date:  2006-01       Impact factor: 2.490

Review 7.  Infection of the endothelium by members of the order Rickettsiales.

Authors:  Gustavo Valbuena; David H Walker
Journal:  Thromb Haemost       Date:  2009-12       Impact factor: 5.249

8.  Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response.

Authors:  Naoya Ukyo; Toshiyuki Hori; Soshi Yanagita; Takayuki Ishikawa; Takashi Uchiyama
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

9.  Endothelial cells present antigens in vivo.

Authors:  Annette L Rothermel; Yinong Wang; Jeffrey Schechner; Barry Mook-Kanamori; William C Aird; Jordan S Pober; George Tellides; David R Johnson
Journal:  BMC Immunol       Date:  2004-03-16       Impact factor: 3.615

10.  Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood.

Authors:  Minji Byun; Cindy S Ma; Arzu Akçay; Vincent Pedergnana; Umaimainthan Palendira; Jinjong Myoung; Danielle T Avery; Yifang Liu; Avinash Abhyankar; Lazaro Lorenzo; Monika Schmidt; Hye Kyung Lim; Olivier Cassar; Melanie Migaud; Flore Rozenberg; Nur Canpolat; Gönül Aydogan; Bernhard Fleckenstein; Jacinta Bustamante; Capucine Picard; Antoine Gessain; Emmanuelle Jouanguy; Ethel Cesarman; Martin Olivier; Philippe Gros; Laurent Abel; Michael Croft; Stuart G Tangye; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2013-07-29       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.